TEM
Tempus AI, Inc.
Is TEM Halal?
AI precision medicine, genomics and clinical-data software — a generally permissible healthcare business whose current debt/assets screen fails.
What You Should Know
Tempus provides AI-enabled precision medicine, genomic diagnostics, clinical data and decision-support software. Its March 31, 2026 Form 10-Q reports assets of $2,135.091 million, debt and operating leases of $1,318.532 million, cash of $521.170 million, receivables of $308.599 million and quarterly revenue of $348.116 million. Debt/assets is 61.76%, liquidity/assets is 24.41% and receivables plus cash/assets is 38.86%; the asset-based debt screen fails. The filing reports $3.866 million of interest income, approximately 1.11% of quarterly revenue, while no universal prohibited-revenue numerator is disclosed.
⚠️ Concerns
- •Known debt/assets is 61.76%, above examined 33.333% limits
- •Receivables-plus-cash/assets is 38.86%, above the examined MSCI 33.33% limit
- •Disclosed interest income is 1.11% of quarterly revenue; no fixed purification percentage asserted
- •Convertible notes, revolver and operating leases require continuing review
- •No universal prohibited-revenue numerator is disclosed
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-15.
1,318.532 / 2,135.091
521.17 / 2,135.091
829.769 / 2,135.091
3.866 / 348.116
- Financial
- Fails
- Overall
- Fails
Debt/assets is 61.76%, above the examined 33.333% limit; liquidity/assets is 24.41%, receivables-plus-cash/assets is 38.86% and disclosed interest income is 1.11%.
- Financial
- Fails
- Overall
- Fails
Debt/assets is 61.76% and receivables-plus-cash/assets is 38.86%, above the examined MSCI limits; liquidity/assets is 24.41%.
- Financial
- Fails
- Overall
- Fails
Debt/assets is 61.76%, above the examined Malaysia limit; liquidity/assets is 24.41%. This is not an official classification.
- Financial
- Not calculated
- Overall
- Fails
A licensed historical market-cap series is not stored; the total-assets debt screen already fails.
Business-activity disclosure
Tempus provides AI-enabled precision medicine, genomic diagnostics, clinical data and software. These healthcare activities are generally permissible, while customer, clinical and data-use allocation remains qualitative.
Limitation: The filing does not allocate revenue into a universal prohibited-activity numerator by customer use, clinical workflow or data-license purpose.
Purification
Tempus discloses $3.866 million of interest income, but no scholar-specific purification percentage or universal prohibited-revenue numerator is provided.
Inputs, assumptions and primary sources
- Amounts are USD millions from Tempus AI's March 31, 2026 Form 10-Q.
- Debt includes the $199.279 million convertible promissory note, $100.000 million revolving credit facility, $204.624 million long-term debt, $729.267 million convertible senior notes and $85.362 million of operating-lease liabilities.
- Cash and cash equivalents are $521.170 million. The $117.902 million marketable-equity-securities balance is not treated as an interest-bearing security.
- Accounts receivable, net are $308.599 million and first-quarter revenue is $348.116 million.
- The filing separately discloses $3.866 million of interest income, approximately 1.11% of quarterly revenue.
- Precision medicine, diagnostics, clinical data and decision-support software are generally permissible, but no universal prohibited-revenue numerator is disclosed.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →